Fidelity SPDR Advertisement
Home > Boards > US Listed > Biotechs >

GW Pharmaceuticals Plc ADS (GWPH)

GWPH RSS Feed
Add GWPH Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator frenchee, newmedman, SymphonicDelight, aparatchik
Search This Board:
Last Post: 10/24/2014 11:22:33 AM - Followers: 190 - Board type: Free - Posts Today: 1
  

 

 
Founded in 1998, GW is a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. GW commercialized the world's first plant-derived cannabinoid prescription drug, Sativex(R), which is approved for the treatment of spasticity due to multiple sclerosis in 25 countries. Sativex is also in Phase 3 clinical development as a potential treatment of pain in people with advanced cancer. This Phase 3 program is intended to support the submission of a New Drug Application for Sativex in cancer pain with the U.S. Food and Drug Administration and in other markets around the world. GW has a deep pipeline of additional cannabinoid product candidates, including Epidiolex which has received Orphan Drug Designation from the FDA for the treatment of Dravet and Lennox-Gastaut syndromes, severe, drug-resistant epilepsy syndromes. GW's product pipeline also includes compounds in Phase 1 and 2 clinical development for glioma, ulcerative colitis, type-2 diabetes, and schizophrenia. For further information, please visit www.gwpharm.com 
 


GWPH Analyst Stock Ratings:

Citigroup - Target Cut from $97 to $86 - 6/30/14

Morgan Stanley - Overweight - $103 - 5/19/14 (Restated) 4/22/14 (Initiated)

Bank of America - Buy - $110 - 3/11/14

Piper Jaffray - Overweight - $147 - 6/30/14


 
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
GWPH
Current Price
Volume:
Bid Ask Day's Range
Wiki
PostSubject
#2786  Sticky Note Intermediate-Term Musings frenchee 09/29/14 02:27:49 PM
#1913  Sticky Note New York Partners with GW Pharmaceuticals SymphonicDelight 06/09/14 02:51:35 PM
#1591  Sticky Note Sativex Receives FastTrack Designation From FDA (CancerPain) SymphonicDelight 04/28/14 07:02:10 AM
#2845   Cannabis Pharma Journal, Featuring GWPH and IMLFF. PharmaGreen007 10/24/14 11:22:33 AM
#2844   Big investor in GWPH, very happy to see PharmaGreen007 10/23/14 03:46:17 PM
#2843   I'd wait till after 2 30 est today ALL IN2 10/22/14 12:57:19 PM
#2842   did i miss bad news somewhere today or codfather 10/22/14 12:36:54 PM
#2841   BREAKING NEWS: LONDON, Oct. 22, 2014 (GLOBE NEWSWIRE) -- FSUBCSchamps 10/22/14 07:21:38 AM
#2840   Zach #1 UnderOath-KY 10/21/14 03:37:12 PM
#2839   Looking strong. Glad I picked some up at FSUBCSchamps 10/21/14 11:33:09 AM
#2838   LMAO, any stock was a good stock to newmedman 10/18/14 09:59:38 AM
#2837   I told you this was a great stock Mohanerie 10/17/14 05:17:18 PM
#2836   Seeing u still around gives me confidence lol Gregwit 10/17/14 03:30:05 PM
#2835   Ha Ha. \ newmedman 10/17/14 03:08:40 PM
#2834   THIS eBOLA STUFF IS GETTING OUT OF CONTROL. niclovlee 10/15/14 10:08:26 PM
#2833   Yesterday's drop, coming after fair to middling results aparatchik 10/15/14 07:53:01 AM
#2832   FDA likes rufinamides... $GWPH Global Interface 10/15/14 12:03:44 AM
#2831   $GWPH GW Pharmaceuticals Is Undervalued Based On The maytepper 10/14/14 02:26:01 PM
#2830   GW Pharma's cannabis-based drug comes up short in honeymooner 10/14/14 10:22:38 AM
#2829   Wow I am stunned. Good results and its FSUBCSchamps 10/14/14 10:17:49 AM
#2828   Negative, ghost rider. barro50 10/14/14 10:05:55 AM
#2827   Amazing test results... To the moon mp40bran 10/14/14 09:02:20 AM
#2826   GW Pharmaceuticals Announces New Physician Reports of Epidiolex(R) Gregwit 10/14/14 07:10:12 AM
#2825   The last trade before close was a 34,000 codfather 10/11/14 05:10:43 AM
#2824   GWPH Technical Analysis Video FutureMeDead 10/10/14 03:10:19 PM
#2823   Yea it's 14 FSUBCSchamps 10/10/14 01:32:21 PM
#2822   What's the significance of this? Is Akynzeo in lesgetrich 10/10/14 01:24:17 PM
#2821   FDA clears Akynzeo for chemo-induced nausea and vomiting Gregwit 10/10/14 11:20:09 AM
#2820   What is going on?! Gwp.l is tanking in honeymooner 10/10/14 10:49:39 AM
#2818   I have not listened to the interview yet, uptoday 10/10/14 10:10:05 AM
#2817   All that aside am I the only one FSUBCSchamps 10/09/14 04:10:31 PM
#2816   Could not agree with you more FSUBCSchamps 10/09/14 03:51:12 PM
#2815   Do you think that US insurance companies don't lesgetrich 10/09/14 01:28:49 PM
#2814   There are no other drugs available that help codfather 10/09/14 12:48:55 PM
#2813   Let's not call them consumers, they are patients! FSUBCSchamps 10/09/14 12:04:45 PM
#2812   They're simply saying that any added benefit of lesgetrich 10/09/14 11:25:22 AM
#2811   I believe the results posted on here were FSUBCSchamps 10/09/14 07:17:33 AM
#2810   It's all about US fda approval. That's why mp40bran 10/08/14 02:31:27 PM
#2809   must have been divine intervention left an order codfather 10/08/14 02:25:46 PM
#2808   U.S. Will save GW... We need new medicine for mp40bran 10/08/14 11:00:36 AM
#2807   NICE says it is not cost effective. When honeymooner 10/08/14 10:53:06 AM
#2806   Did I miss something the clinical results looked ALL IN2 10/08/14 10:39:24 AM
#2805   Gwp.l is tanking on the NICE Sativex rejection. honeymooner 10/08/14 10:17:53 AM
#2804   Sativex study: ADVFN_wengerb 10/05/14 11:04:15 AM
#2803   Yea they all said to buy Gregwit 10/04/14 05:48:32 PM
#2802   Any news/updates from the CEOs speech at the aparatchik 10/04/14 01:52:35 PM
#2801   Thank you!! She sure is turning bullish. Your FSUBCSchamps 10/03/14 09:41:34 AM
#2800   GWPH chart: BULLISH PIERCING LINE "forming" on the ospreyeye 10/02/14 03:00:55 PM
#2799   I bought at 80 and 76 FSUBCSchamps 10/02/14 01:01:14 PM
#2798   Same here...Added this morning. This is now thescooter77 10/02/14 09:39:43 AM
#2797   I decided to take my chances and added uptoday 10/02/14 09:03:54 AM
#2796   The Street: thescooter77 10/02/14 09:01:36 AM
#2795   Did he mention them? mp40bran 10/01/14 08:31:43 PM
PostSubject